Comparing the incidence of postoperative nausea and vomiting in groups using intraoperative remimazolam versus not using intraoperative remimazolam

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008812

Enrollment

Registered

2023-09-21

Start date

2023-07-03

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Study of the difference in the incidence of PONV between sevoflurane and remimazolam for induction and maintenance of anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects between 20 and 80 years of age Subjects scheduled to undergo laparoscopic surgery under general anesthesia in the central operating room of Pusan National University Hospital (Remimazolam: 40 subjects, Sevoflurane: 40 subjects) Subjects who belong to the American Society of Anesthesiologists (ASA) Physical Status Classification (PSC) levels 1-3 Subjects who have voluntarily agreed in writing to participate in this clinical study.

Exclusion criteria

Exclusion criteria: ASA 4 or higher Subjects who are allergic to remimazolam or sevoflurane. Subjects without renal, hepatic, neuromuscular, or neurologic disease and taking medications related to them. Subjects habitually taking psychoactive drugs or with ischemic heart disease. Excludes pregnant women.

Design outcomes

Primary

Measure	Time frame
Difference of PONV with remimazolam versus sevoflurane	—

Secondary

Measure	Time frame
KQOR-15 score difference in remimazolam versus sevoflurane group	—

Countries

Korea, Republic of

Contacts

Public ContactYeong-Min Yoo

Pusan National University Yangsan Hospital

rym721@naver.com+82-55-360-2129

Outcome results